The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors

Overview

Aim: To determine the effects of health education about Human Papilloma Virus infection and cervical cancer prevention on knowledge, attitudes, beliefs and behaviors of adolescent girls and their mothers.

Background: To combat with cervical cancer, it is urgent that prevention Human Papilloma Virus related disease all around the world.

Design: A randomized trial with a control group (n=108) and an intervention group (n=108).

Methods: The study was applied between January to June 2019 in the two different adolescent outpatient clinics in Turkey. The outpatient clinics were randomly assigned as intervention and control groups by numbering and opaque and sealed envelopes. Based on the intention-to-treat principle, all participants were analyzed according to the group they were assigned to, regardless of whether they received the intervention or not. In addition to the routine clinical practice, the adolescent girls and their mothers who participated in the intervention group were given health education twice in the first interview and in the fifth week. Follow-up continued for 12 weeks. The adolescent girls and their mothers in the control group received routine clinical practice. The effects of health education were evaluated with Human Papilloma Virus Knowledge Scale and Health Belief Model Scale for Human Papilloma Virus and its Vaccination.

Impact: Human Papilloma Virus vaccine, which has an important place in primary protection from cervical cancer, is expected to provide effective results by facilitating access to vaccine accompanied with health education.

Full Title of Study: “The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors of Adolescent Girls and Their Mothers: A Prospective Randomized Controlled Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 15, 2019

Interventions

  • Behavioral: Health Education
    • the adolescent girls and their mothers who participated in the intervention group were given health education twice in the first interview and in the fifth week. Follow-up continued for 12 weeks. The adolescent girls and their mothers in the control group received routine clinical practice. The effects of health education were evaluated with Human Papilloma Virus Knowledge Scale and Health Belief Model Scale for Human Papilloma Virus and its Vaccination.

Arms, Groups and Cohorts

  • Experimental: intervention group
    • Health education is given intervention group and 12 weeks follow up.
  • No Intervention: control group
    • Control group takes standard health care and 12 weeks follow up.

Clinical Trial Outcome Measures

Primary Measures

  • Health Belief Model Scale for Human Papilloma Virus and Vaccine
    • Time Frame: three months
    • In the four-point Likert scale, each item is scored between “none = 1″ and “too much = 4.. The lowest score is 14 and the highest score is 56.
  • Human Papilloma Virus Knowledge Scale
    • Time Frame: three months
    • True 1 “points are given to the correct answers given by the participants to each item, and” 0 “points are given to wrong and undecided’ ‘answers with incorrect answers. The lowest score that can be obtained from the scale is “0″ and the highest is “10″.

Secondary Measures

  • Human Papilloma Virus Knowledge Scale
    • Time Frame: three months
    • rue 1 “points are given to the correct answers given by the participants to each item, and” 0 “points are given to wrong and undecided’ ‘answers with incorrect answers. The lowest score that can be obtained from the scale is “0″ and the highest is “10″.
  • Health Belief Model Scale for Human Papilloma Virus and Vaccine
    • Time Frame: three months
    • In the four-point Likert scale, each item is scored between “none = 1″ and “too much = 4.. The lowest score is 14 and the highest score is 56.

Participating in This Clinical Trial

Inclusion Criteria

To be a girl between the ages of 9 and 18, to be a mother of a girl between the ages of 9 and 18, to be fluent in Turkish, to be literate

Exclusion Criteria

to be male, to have previously received Human Papilloma Virus vaccination, to have hearing, speech impairment and mental disorder, not to follow the study regularly, to use medication due to psychotic treatments, to be an adolescent with sexual experience

Gender Eligibility: Female

Minimum Age: 9 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
  • Provider of Information About this Clinical Study
    • Principal Investigator: Serpil Ozdemir, PhD, RN, Assistant Professor – Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.